Comparison of Two Relaxation Strategies Between Glasses, Virtual Reality Headset, and Without Relaxation Tool, in the Anxiety Preoperative of Orthopedic Adult Patients
RELAXPREOP
1 other identifier
interventional
632
1 country
1
Brief Summary
In adults, the prevalence of preoperative anxiety related to surgery or anesthesia ranges from 60 to 80%, and context plays an important role. Patients with significant preoperative anxiety experience reduced sleep quality. In addition, high preoperative anxiety is linked to more severe postoperative pain and an increased need for painkillers. In addition, it is a source of dysfunction in care. Currently, there are no recommendations regarding the prevention of preoperative anxiety. New approaches have emerged that show some benefit: music, binaural auditory stimulation and hypnosis. In the UAC J0 unit of the Amiens-Picardie University Hospital, the caregivers offer the PSiO glasses, a tool combining three techniques: light therapy, relaxation and chromotherapy. This system has obtained CE and FCC markings and seems to be more or less effective on patients admitted to the CH . A pilot study evaluating the effects of virtual reality hypnosis on patients' preoperative anxiety has shown that this technology represents a non-invasive way to reduce preoperative stress levels without side effects and without the need for additional medical or paramedical staff. This study aims to improve the patient's well-being before their operation. Depending on the randomization, he will benefit from a relaxation session with the Psio glasses or a virtual reality hypnosis session with the Hypno VR headset. Follow-up of patients will be carried out on the basis of variation in an anxiety scale, physiological criteria, the amount of anesthetic products used, the time spent in the recovery room, and the evaluation of pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 23, 2026
CompletedFirst Posted
Study publicly available on registry
April 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
April 29, 2026
April 1, 2026
1 year
April 23, 2026
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variation in the score on the APAIS anxiety scale
Variation in the score on the APAIS scale, 6-item scale rated from 1 to 5 The anxiety score sums items 1, 2, 4 and 5 (\>11 = anxious subjects) The information desire score sums items 3 and 6 (2 to 4 = refusal of information, 5 to 7 = average desire for information, \>7 = eager desire for information)
1 hour
Secondary Outcomes (7)
Heart rate variation
1 hour
Variation in respiratory rate
over 1 minute
Blood pressure variation
1 hour
Variation in oxygen saturation
1 hour
Quantity of product used
1 hour
- +2 more secondary outcomes
Study Arms (3)
HypnoVR group
EXPERIMENTALThe patient will benefit from a 20-minute virtual reality hypnosis session in the universe of his choice. The experience consists of hypnotic speech, adapted to the study population, inducing a state of relaxation (guided breathing sequences, cardiac coherence exercises, positive suggestions), an evolving 3D virtual journey and a musical atmosphere.
PSIO Group
EXPERIMENTALthe patient will be given a 20-minute relaxation session with the PSiO® glasses. The experience consists of a visual stage with shimmering colors and music.
Group without relaxation tool
SHAM COMPARATORthe patient will wait 20-minute, without benefit of sendorial tools.
Interventions
the patient will be given a 20-minute relaxation session with the PSiO® glasses. The experience consists of a visual stage with shimmering colors and music.
The patient will benefit from a 20-minute virtual reality hypnosis session in the universe of his choice. The experience consists of hypnotic speech, adapted to the study population, inducing a state of relaxation (guided breathing sequences, cardiac coherence exercises, positive suggestions), an evolving 3D virtual journey and a musical atmosphere.
Group without relaxation tool: the patient will wait 20-minute, without benefit of sendorial tools.
Eligibility Criteria
You may qualify if:
- Patient treated at the UAC D0
- Orthopedic patient (arthroplasty mainly)
- Anesthesic procedure with general anesthesia
- Patient \>18 years old without cognitive impairment in the investigator's judgment
- Patient who has signed a free and informed consent
- Patient affiliated to a social security scheme
You may not qualify if:
- Patient with deafness that does not allow him to perceive and understand sounds
- Patient with a visual impairment who does not allow him to watch and understand a video
- Patient who does not master the French language (spoken, written and read)
- Patient with a history of epilepsy
- Patient with a history of migraine/headache when using a virtual reality headset
- Patients with a history of dizziness triggered by images (film, video game...)
- Patient with untreated dry eye disease
- Patient with psychiatric diseases and disorders not compatible with the study in the investigator's judgment
- Patient who is pregnant, parturient, or breastfeeding.
- Patient under guardianship or curatorship, under judicial protection or deprived of public law
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amiens University Hospital
Amiens, Picardie, 80054, France
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2026
First Posted
April 29, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share